Treatment of Breast Cancer after Surgery. What Primary Care Providers Need to Know

Size: px
Start display at page:

Download "Treatment of Breast Cancer after Surgery. What Primary Care Providers Need to Know"

Transcription

1 Treatment of Breast Cancer after Surgery What Primary Care Providers Need to Know

2 Disclosure of Potential for Conflict of Interest Dr. Chris Ogaranko Treatment of Breast Cancer after Surgery FINANCIAL DISCLOSURE Grants/Research Support: None Speaker bureau/honoraria amounts: None Consulting fees: None Other: None

3 Learning Objectives Understand the usual sequence of postsurgical breast cancer treatments Explain the rationale for these treatment, their basic indications, benefits and toxicities Recognize opportunities for important primary care input during treatment

4 Breast Cancer Treatment Rationale Treatment after complete surgical resection to kill micrometastases; decrease cancer recurrence and improve survival Chemotherapy before surgery if the tumour is large (>5cm) +/- advanced lymphadenopathy to improve resection

5 Breast Cancer Treatment Timeline

6 Who Gets Chemo? Bottom Line (with exceptions): Node + and those > 1 cm get chemo. Node and those < 1 cm (especially cm) may get chemo.

7 Who Gets Chemo?-Tools Adjuvant! Online what is the risk for recurrence and death? Age and health status Lymph node status Size of tumour ER status

8

9 Genetic Testing

10 Common Chemotherapies FEC-D regimen: fluorouracil, epirubicin, cyclophosphamide x 3 cycles, and then docetaxel x 3 cycles Fit, higher risk patients TC regimen: Taxotere/docetaxel with cyclophosphamide x 4 cycles Less fit, lower risk patients Both are 21 day cycles

11 Toxicities (short-term) General: fatigue, myalgias, allergic, fluid retension Skin/membranes: rash, stomatitis (Candida), nails, alopecia GI: anorexia, N/V, diarrhea/constipation, colitis GU: vaginitis, cystitis, amenorrhea Marrow: myelosuppression, febrile neutropenia, sepsis Cardiac: CHF Peripheral neuropathy

12 Long-term Complications Of Chemotherapy Premature Menopause especially if older than 40 Cardiac dysfunction Cognitive changes chemo. brain poorly understood Second cancers - AML, MDS Peripheral Neuropathy Fatigue Psychological depression, insomnia

13 Who Gets Radiation? Post-lumpectomy: all Lowers risk of local recurrence (15-20% ARR) Improves overall survival (~ 5% ARR) 5 days per week for 3 5 weeks Usually starts one month after chemotherapy

14 Who Gets Radiation? Post-mastectomy: indications variable, but for sure if: tumor > 5cm at least 4 +ve LN s (and often for 1-3 nodes) +ve deep margin

15 Short-Term Radiation Side Effects Arm edema (especially axillary RT) Pneumonitis (transient; <5%) Fatigue Skin reactions

16 Long-term Complications Of Radiation Lymphedema (arm, breast, chest) Brachial Plexopathy Cardiac Dysfunction Second Cancers (1% - sarcoma, lung esophagus)

17 Endocrine Therapy for ER/PR+ Premenopausal: Tamoxifen for 5 years (will this become 10 years?) Postmenopausal: Aromatase Inhibitors (AI s) preferred e.g. letrozole, exemestane Different strategies for AI use Up front After 2-3 years of tamoxifen Extended adjuvant use after 5 years tamoxifen Started after radiation completed

18 Current Endocrine Strategies Postmenopausal Women Tamoxifen AI 0 Yrs **NEW: 10 years tamoxifen may be better** 5 Yrs 10 Yrs

19 Side Effects Tamoxifen: watch out for interactions a) Short-term: N/V, vaginal, hot flashes b) Long-term: DVT, uterine CA and cataracts Aromatase Inhibitors: a) Short-term: same plus arthralgias (lots) b) Long-term: lipids, bones,?ihd

20 Herceptin Herceptin/trastuzumab ~ 20% breast cancers overexpress HER2 Indication: tumour > 0.5 cm or node + no CHF (EF > 55%) Given i.v. q3 weeks for one year Main toxicity is cardiac (MUGA q3 months)

21 Interactions with Breast CA Treatment Chemo: warfarin, metronidazole, thiazides, phenytoin Herceptin: few Tamoxifen: paroxetine, fluoxetine, ketaconazole, trazodone, estrogen Aromatase Inhibitors: estrogen

22 Primary Care Issues Soy and flax seem to be OK Exercise may lower recurrence Timing matters for influenza and pneumococcal immunizations on chemo. Don t give live virus vaccines on chemo. Calcium (dietary) and vitamin D for bones Screen for, and treat psychological issues

23 Take Home Pearls Breast cancer treatment is a long journey with a variety of therapies to reduce the risk of recurrence and death Primary care providers can support patients, monitor/treat issues like psychological distress, assist with symptom management and recognize potential complications Consider interactions with cancer treatments

Remember: Not everyone experiences these persistent and late side effects.

Remember: Not everyone experiences these persistent and late side effects. Persistent and Late Effects of Breast Cancer and Breast Cancer Treatment PMH You may have already experienced side effects from cancer and its treatment. Fortunately, most side effects are short-lived

More information

Breast Cancer. Breast Cancer Page 1

Breast Cancer. Breast Cancer Page 1 Breast Cancer Summary Breast cancers which are detected early are curable by local treatments. The initial surgery will give the most information about the cancer; such as size or whether the glands (or

More information

Breast Cancer Treatment Guidelines

Breast Cancer Treatment Guidelines Breast Cancer Treatment Guidelines DCIS Stage 0 TisN0M0 Tamoxifen for 5 years for patients with ER positive tumors treated with: -Breast conservative therapy (lumpectomy) and radiation therapy -Excision

More information

I will be having surgery and radiation treatment for breast cancer. Do I need drug treatment too?

I will be having surgery and radiation treatment for breast cancer. Do I need drug treatment too? What is node-positive breast cancer? Node-positive breast cancer means that cancer cells from the tumour in the breast have been found in the lymph nodes (sometimes called glands ) in the armpit area.

More information

GUIDELINES ADJUVANT SYSTEMIC BREAST CANCER

GUIDELINES ADJUVANT SYSTEMIC BREAST CANCER GUIDELINES ADJUVANT SYSTEMIC BREAST CANCER Author: Dr Susan O Reilly On behalf of the Breast CNG Written: December 2008 Agreed at CNG: June 2009 & June 2010 Review due: June 2011 Guidelines Adjuvant Systemic

More information

Metastatic Breast Cancer: The Art and Science of Systemic Therapy. Vallerie Gordon MD, FRCPC Medical Oncologist CancerCare Manitoba

Metastatic Breast Cancer: The Art and Science of Systemic Therapy. Vallerie Gordon MD, FRCPC Medical Oncologist CancerCare Manitoba Metastatic Breast Cancer: The Art and Science of Systemic Therapy Vallerie Gordon MD, FRCPC Medical Oncologist CancerCare Manitoba Presenter Disclosure Faculty: Dr. Vallerie Gordon Relationships with commercial

More information

Breast Cancer Educational Program. June 5-6, 2015

Breast Cancer Educational Program. June 5-6, 2015 Breast Cancer Educational Program June 5-6, 2015 Adjuvant Systemic Therapy For Early Breast Cancer: Who, What and for How Long? Debjani Grenier MD, FRCPC Medical Oncologist Disclosures Advisory Board Member:

More information

Breast Cancer Treatment

Breast Cancer Treatment Breast Cancer Treatment Most women with breast cancer will have surgery. The two common types of surgery are breast-conserving surgery and mastectomy. Breast Conserving Surgery A lumpectomy removes only

More information

Clinical Management Protocol Chemotherapy Breast Cancer. Protocol for Planning and Treatment

Clinical Management Protocol Chemotherapy Breast Cancer. Protocol for Planning and Treatment Protocol for Planning and Treatment The process to be followed when a course of chemotherapy is required to treat: BREAST CANCER Patient information given at each stage following agreed information pathway

More information

BREAST CANCER WHAT HAPPENS AFTER SURGERY?

BREAST CANCER WHAT HAPPENS AFTER SURGERY? BREAST CANCER WHAT HAPPENS AFTER SURGERY? Contents: Planning further treatment Medical management of breast cancer Support and follow up Questions to ask your surgeon or oncologist Planning further treatment

More information

Adjuvant Therapy for Breast Cancer: Questions and Answers

Adjuvant Therapy for Breast Cancer: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast

More information

BreastCancerTrials.org History Form: Metastatic Breast Cancer ABOUT ME

BreastCancerTrials.org History Form: Metastatic Breast Cancer ABOUT ME BreastCancerTrials.org History Form: Metastatic Breast Cancer This form is for patients with metastatic breast cancer who were: Were recently diagnosed with metastatic breast cancer (cancer that has spread

More information

Florida Breast Health Specialists Breast Cancer Information and Facts

Florida Breast Health Specialists Breast Cancer Information and Facts Definition Breast cancer is a cancer that starts in the tissues of the breast. There are two main types of breast cancer: Ductal carcinoma starts in the tubes (ducts) that move milk from the breast to

More information

New Treatment Options for Breast Cancer

New Treatment Options for Breast Cancer New Treatment Options for Breast Cancer Brandon Vakiner, PharmD., BCOP Clinical Pharmacy Specialist - Oncology The University of Iowa Hospitals and Clinics Assistant Professor (Clinical) University of

More information

HORMONE THERAPY AND CHEMOTHERAPY

HORMONE THERAPY AND CHEMOTHERAPY A SHARED DECISION-MAKING PROGRAM Early breast cancer HORMONE THERAPY AND CHEMOTHERAPY Are they right for you? BCA001B V06 Early breast cancer HORMONE THERAPY AND CHEMOTHERAPY Are they right for you? This

More information

The Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation

The Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation The Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation Prof. Eva Grunfeld, MD, DPhil, FCFP Ontario Institute for Cancer Research/Cancer Care

More information

Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue

Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue page 1 Early-stage Breast Cancer Treatment: A Patient and Doctor Dialogue Q: What is breast cancer, and what type do I have? A: Cancer is a disease in which cells become abnormal and form more cells in

More information

Breast Cancer Update 2014 Prevention, Risk, and Treatment of Early Stage Breast Cancer. Kevin R. Fox, MD University of Pennsylvania

Breast Cancer Update 2014 Prevention, Risk, and Treatment of Early Stage Breast Cancer. Kevin R. Fox, MD University of Pennsylvania Breast Cancer Update 2014 Prevention, Risk, and Treatment of Early Stage Breast Cancer Kevin R. Fox, MD University of Pennsylvania Prevention of Breast Cancer Accepted treatments Tamoxifen (premenopausal

More information

BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer ABOUT ME

BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer ABOUT ME BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer This form is for patients with DCIS or early stage invasive cancer who are: On hormone therapy after breast cancer surgery Or

More information

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Update in Hematology Oncology Targeted Therapies. Mark Holguin Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning

More information

Breast Pathway Group FEC 60 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer in Elderly / Frail

Breast Pathway Group FEC 60 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer in Elderly / Frail Breast Pathway Group FEC 60 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer in Elderly / Frail Indication: Neoadjuvant or adjuvant therapy for elderly and frail patients with breast

More information

Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer

Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer Breast Studies Adjuvant therapy after surgery Her 2 positive Breast Cancer B 52 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients with Hormone

More information

Metastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011

Metastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011 Metastatic Breast Cancer 201 Carolyn B. Hendricks, MD October 29, 2011 Overview Is rebiopsy necessary at the time of recurrence or progression of disease? How dose a very aggressive treatment upfront compare

More information

5.04.20. Perjeta. Perjeta (pertuzumab) Description

5.04.20. Perjeta. Perjeta (pertuzumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.04.20 Subject: Perjeta Page: 1 of 5 Last Review Date: June 19, 2015 Perjeta Description Perjeta (pertuzumab)

More information

CLINICAL POLICY Department: Medical Management Document Name: HER2 Breast Cancer Treatments

CLINICAL POLICY Department: Medical Management Document Name: HER2 Breast Cancer Treatments Page: 1 of 11 Specialist Review: Revised: 06/13 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review

More information

West of Scotland Cancer Network Systemic Anti-Cancer Therapy Protocol

West of Scotland Cancer Network Systemic Anti-Cancer Therapy Protocol West of Scotland Cancer Network Systemic Anti-Cancer Therapy Protocol FEC-DH in the adjuvant treatment of Breast Cancer (BRWOS- 031/1) Indication Adjuvant chemotherapy for HER2+ve Early Breast Cancer Eligibility

More information

Breast cancer treatments

Breast cancer treatments Breast cancer treatments i About us Breast Cancer Network Australia (BCNA) is the peak organisation for all people affected by breast cancer in Australia. We provide a range of free resources, including

More information

What s New With HER2?

What s New With HER2? What s New With HER2? Trastuzumab emtansine and pertuzumab for metastatic breast cancer Lindsay Livingston Pharmacist CancerCare Manitoba October 3, 2014 Presenter Disclosure Faculty: Lindsay Livingston

More information

Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer

Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer LONDON CANCER NEWS DRUGS GROUP RAPID REVIEW Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer Everolimus plus exemestane for second-line

More information

Adjuvant Endocrine Therapy in Breast Cancer: 2015 Update

Adjuvant Endocrine Therapy in Breast Cancer: 2015 Update Adjuvant Endocrine Therapy in Breast Cancer: 2015 Update Shannon Puhalla, MD Director, Breast Cancer Clinical Research Program Magee Womens Cancer Program University of Pittsburgh Cancer Institute Questions

More information

What is breast cancer?

What is breast cancer? Breast Cancer What is breast cancer? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines BREAST CANCER: A GUIDE FOR

More information

New strategies in anticancer therapy

New strategies in anticancer therapy 癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive

More information

Breast Cancer: Management and Follow-Up

Breast Cancer: Management and Follow-Up Breast Cancer: Management and Follow-Up Effective Date: October 1, 2013 Scope This guideline provides recommendations for management and follow-up of biopsy-proven breast cancer in women aged 19 years.

More information

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors. 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors. 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D. Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D., FACS Learning Objectives After reading and reviewing this

More information

La personalizzazione terapeutica: quanto influisce l età

La personalizzazione terapeutica: quanto influisce l età La personalizzazione terapeutica: quanto influisce l età PierFranco Conte University of Padova Department of Surgery, Oncology and Gastroenterology IOV Istituto Oncologico Veneto I.R.C.C.S. Breast Cancer

More information

X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary

X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary X-Plain Chemotherapy for Breast Cancer - Adriamycin, Cytoxan, and Tamoxifen Reference Summary Introduction Breast cancer is a common condition that affects one out of every 11 women. Your doctor has recommended

More information

Early and Locally Advanced Breast

Early and Locally Advanced Breast Early and Locally Advanced Breast Cancer Audrea H. Szabatura, Pharm.D., BCOP; and Amy Hatfield Seung, Pharm.D., BCOP Reviewed by Jared M. Freml, Pharm.D., BCOP; Clarence Chant, Pharm.D., BCPS, FCSHP; and

More information

After Radiation Therapy

After Radiation Therapy After Radiation Therapy CHRISTOPHER G. JORDAN, DO, FACOI UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER DIRECTOR, SECTION OF HEMATOLOGY & ONCOLOGY MAY 1, 2015 A brief Understanding of Radiation Multiple

More information

Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer

Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer Background: A non-anthracycline based regimen for high-risk, HER 2 positive breast cancer in the adjuvant setting (BCIRG 006). Patient

More information

Breast Pathway Group AC (Doxorubicin / Cyclophosphamide) in Early Breast Cancer

Breast Pathway Group AC (Doxorubicin / Cyclophosphamide) in Early Breast Cancer Breast Pathway Group AC (Doxorubicin / Cyclophosphamide) in Early Breast Cancer Indication: Neoadjuvant or adjuvant treatment of breast cancer Regimen details: Doxorubicin 60mg/m 2 IV Day 1 Cyclophosphamide

More information

Testosterone Therapy for Women

Testosterone Therapy for Women Testosterone Therapy for Women The Facts You Need Contents 2 INTRODUCTION: The Facts You Need... 3-4 CHAPTER 1: Testosterone and Women... 5-9 CHAPTER 2: Testosterone Therapy for Women... 10-14 CONCLUSION:

More information

Guideline for the Non Surgical Treatment of Breast Cancer

Guideline for the Non Surgical Treatment of Breast Cancer Guideline for the Non Surgical Treatment of Breast Cancer incorporating former guidelines for systemic treatment, radiotherapy and aromatase inhibitors. Version History Version Date Comments 2.0 20.02.08

More information

Hormone Therapy with Tamoxifen

Hormone Therapy with Tamoxifen What is hormone-receptor-positive breast cancer? Many breast cancers need estrogen and/or progesterone (female hormones), to grow and spread. When breast cancer is found, the cancer is tested for two proteins,

More information

Probe: Could you tell me about when?

Probe: Could you tell me about when? PERIODIC ASSESSMENT OF TREATMENT AND VITAL/DISEASE STATUS Periodic Assessment of Cancer Treatment and Disease Status (To be administered to patient at 3 months and reviewed at 6, 9 and 12 months) Instructions:

More information

2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) IMPTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory

More information

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years

More information

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including

More information

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor. Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast

More information

Stage II breast cancer

Stage II breast cancer CHAPTER 10 Stage II breast cancer Lori Jardines, MD, Bruce G. Haffty, MD, and Melanie Royce, MD, PhD This chapter focuses on the treatment of stage II breast cancer, which encompasses primary tumors >

More information

When it comes to treating breast cancer, doing less does more October is Breast Cancer Awareness Month

When it comes to treating breast cancer, doing less does more October is Breast Cancer Awareness Month For Immediate Release Oct. 8, 2012 When it comes to treating breast cancer, doing less does more October is Breast Cancer Awareness Month SEATTLE Oncologists and researchers are discovering that when it

More information

GENERAL QUESTIONS FOR YOUR DOCTOR OR NURSE. 3. Can you refer me to a breast cancer support group or counselor?

GENERAL QUESTIONS FOR YOUR DOCTOR OR NURSE. 3. Can you refer me to a breast cancer support group or counselor? GENERAL QUESTIONS FOR YOUR DOCTOR OR NURSE 1. You can bring members of your family or a friend to talk to the doctor or nurse directly. 2. Where can I find more information about breast cancer? 3. Can

More information

Breast Pathway Group FEC(100)-Docetaxel: Fluorouracil / Epirubicin / Cyclophosphamide followed by Docetaxel in Early Breast Cancer

Breast Pathway Group FEC(100)-Docetaxel: Fluorouracil / Epirubicin / Cyclophosphamide followed by Docetaxel in Early Breast Cancer Breast Pathway Group FEC(100)-Docetaxel: Fluorouracil / Epirubicin / Cyclophosphamide followed by Docetaxel in Indication: Neoadjuvant or adjuvant therapy in node positive patients. Also considered in

More information

SIDE EFFECTS REVISITED: Women s Experiences With Aromatase Inhibitors

SIDE EFFECTS REVISITED: Women s Experiences With Aromatase Inhibitors SIDE EFFECTS REVISITED: Women s Experiences With Aromatase Inhibitors A Report From Breast Cancer Action JUNE 2008 SIDE EFFECTS REVISITED: Women s Experiences With Aromatase Inhibitors By Marilyn T. Zivian,

More information

dedicated to curing BREAST CANCER

dedicated to curing BREAST CANCER dedicated to curing BREAST CANCER When you are diagnosed with breast cancer, you need a team of specialists who will share their knowledge of breast disease and the latest treatments available. At Cancer

More information

BCCA Protocol Summary for Palliative Therapy for Metastatic Breast Cancer using Trastuzumab Emtansine (KADCYLA)

BCCA Protocol Summary for Palliative Therapy for Metastatic Breast Cancer using Trastuzumab Emtansine (KADCYLA) BCCA Protocol Summary for Palliative Therapy for Metastatic Breast Cancer using Trastuzumab Emtansine (KADCYLA) Protocol Code Tumour Group Contact Physician UBRAVKAD Breast Dr Stephen Chia ELIGIBILITY:

More information

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Current Status and Perspectives of Radiation Therapy for Breast Cancer Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic

More information

Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female

Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,

More information

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine

More information

Appendix A_TAMOXIFEN AND AROMATASE INHIBITOR Survey

Appendix A_TAMOXIFEN AND AROMATASE INHIBITOR Survey Article title: Patient-reported discontinuation of endocrine therapy and related side effects among women with early stage breast cancer Authors: Erin J. Aiello Bowles, Denise M. Boudreau, Jessica Chubak,

More information

National Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div.

National Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div. Dated 21 st November 2014 NPPA Invites Comments of Pharmaceutical Industry & Trade, Consumer Organisations, Public Health Experts and other Stakeholders on the Recommendations of Tata Memorial Centre under

More information

Recommendations for the management of early breast cancer

Recommendations for the management of early breast cancer Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation FEBRUARY 2014 Incorporates published evidence to August

More information

PART THREE: TREATMENTS

PART THREE: TREATMENTS PART THREE: TREATMENTS DECIDING ON TREATMENT It is important that you be given the knowledge you need to enable you to actively participate in decisions about your care and treatment. It is a patient's

More information

Helping you manage symptoms and side effects associated with metastatic breast cancer treatment

Helping you manage symptoms and side effects associated with metastatic breast cancer treatment Helping you manage symptoms and side effects associated with metastatic breast cancer treatment 2015 AstraZeneca. All rights reserved. 3156710 Last Updated 9/15 with metastatic breast cancer treatment

More information

DECISION AND SUMMARY OF RATIONALE

DECISION AND SUMMARY OF RATIONALE DECISION AND SUMMARY OF RATIONALE Indication under consideration Clinical evidence Everolimus in combination with exemestane hormone therapy for oestrogen receptor positive locally advanced or metastatic

More information

Chemotherapy or Not? Anthracycline or Not? Taxane or Not? Does Density Matter? Chemotherapy in Luminal Breast Cancer: Choice of Regimen.

Chemotherapy or Not? Anthracycline or Not? Taxane or Not? Does Density Matter? Chemotherapy in Luminal Breast Cancer: Choice of Regimen. Chemotherapy in Luminal Breast Cancer: Choice of Regimen Andrew D. Seidman, MD Attending Physician Breast Cancer Medicine Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Cornell

More information

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive

More information

Kidney Cancer OVERVIEW

Kidney Cancer OVERVIEW Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney

More information

Drug treatments for early breast cancer

Drug treatments for early breast cancer Drug treatments for early breast cancer Including: Chemotherapy Hormone therapy Targeted (biological) treatments Clinical trials Complementary therapies ABOUT THIS BOOKLET This content is from a larger

More information

Clair Clark, Cancer Care Pharmacist Beatson West of Scotland Cancer Centre

Clair Clark, Cancer Care Pharmacist Beatson West of Scotland Cancer Centre Clair Clark, Cancer Care Pharmacist Beatson West of Scotland Cancer Centre An audit of neutropenic complications in breast cancer patients receiving adjuvant or neo-adjuvant chemotherapy with FEC-D in

More information

Patient Guide to Breast Cancer Surgery and Treatment

Patient Guide to Breast Cancer Surgery and Treatment Patient Guide to Breast Cancer Surgery and Treatment Coree H. Flight attendant and mother of 3. Diagnosed with invasive breast cancer in 2009. An educational guide prepared by Genomic Health This Is Your

More information

Breast Cancer. Your right to know. Illinois Department of Public Health

Breast Cancer. Your right to know. Illinois Department of Public Health Breast Cancer Your right to know Illinois Department of Public Health The information contained in this brochure regarding recommendations for the early detection, diagnosis and treatment of breast disease

More information

Cellular, Molecular, and Biochemical Targets in Breast Cancer

Cellular, Molecular, and Biochemical Targets in Breast Cancer Cellular, Molecular, and Biochemical Targets in Breast Cancer Kristy Kummerow Ingrid Meszoely December 12, 2012 VUMC Resident Bonus Conference One size fits all surgical treatment of breast cancer Wilhelm

More information

Docetaxel, Carboplatin and Trastuzumab (TCH i.e. Taxotere Carboplatin, Herceptin ) for Early Breast Cancer

Docetaxel, Carboplatin and Trastuzumab (TCH i.e. Taxotere Carboplatin, Herceptin ) for Early Breast Cancer Regimen: Docetaxel, Carboplatin and Trastuzumab (TCH i.e. Taxotere Carboplatin, Herceptin ) for Early Breast Cancer Indication Approved for the treatment of early and locally advanced breast cancer in

More information

SAMO FoROMe Post-ESMO 2013 Breast Cancer

SAMO FoROMe Post-ESMO 2013 Breast Cancer SAMO FoROMe Post-ESMO 2013 Breast Cancer Dr. med. Manuela Rabaglio Klinik und Poliklinik für Medizinische Onkologie Breast Cancer Track 300 Abstracts 142 Poster 11 Proffered paper 4 late breaking news

More information

Areola: The area of dark-colored skin on the breast that surrounds the nipple.

Areola: The area of dark-colored skin on the breast that surrounds the nipple. Glossary of Terms Adenocarcinoma: Cancer arising in gland-forming tissue; the medical term meaning related to a gland is adeno ; breast lobules and ducts are types of glands. Adjuvant: Treatment given

More information

Cancer patients waiting for potentially live-saving treatments in UK

Cancer patients waiting for potentially live-saving treatments in UK Cancer patients waiting for potentially live-saving treatments in UK 29 May 2005 UK patients are waiting too long for new treatments, according to a 'Dossier of Delay' compiled by information charity CancerBACUP.

More information

How Breast Cancer Treatment affects Massage Therapy

How Breast Cancer Treatment affects Massage Therapy How Breast Cancer Treatment affects Massage Therapy A Webinar with Tracy Walton, MS, LMT Part 4 of the More about Cancer Care and Massage Webinar Series 11 Background Tracy Walton Author Educator Researcher

More information

Followingcompletionof breastcancertherapy,all patientsshouldbe monitoredin the following manner:

Followingcompletionof breastcancertherapy,all patientsshouldbe monitoredin the following manner: ST. JOHN HEALTH BREAST CARE PROGRAM STANDARD4.3 PATIENT SURVEILLANCE Standard of Care: Followingcompletionof breastcancertherapy,all patientsshouldbe monitoredin the following manner:. History and physical

More information

Florida Breast Health Specialists Hormone Therapy Information and Questions to Ask Your Doctor

Florida Breast Health Specialists Hormone Therapy Information and Questions to Ask Your Doctor What is Hormone Therapy? Hormonal therapy medicines are whole-body (systemic) treatment for hormone-receptorpositive breast cancers. Hormone receptors are like ears on breast cells that listen to signals

More information

New Treatment Advances for Breast Cancer

New Treatment Advances for Breast Cancer New Treatment Advances for Breast Cancer Guest Expert: Lyndsay, MD Director of the Yale Cancer Center Breast Cancer Program Gina ng, MD www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center

More information

Overview: 1. Epidemiology of childhood cancer survivorship 2. Late effects 3. Palliative care of survivors 4. Examples

Overview: 1. Epidemiology of childhood cancer survivorship 2. Late effects 3. Palliative care of survivors 4. Examples Childhood Cancer Survivorship Jacqueline Casillas, M.D., M.S.H.S. Associate Program Director of the UCLA-LIVESTRONG LIVESTRONGTM TM Center of Excellence for Survivorship Care Overview: 1. Epidemiology

More information

Developed by the Cancer Detection Section California Department of Public Health January, 2010 Cancer Detection Programs: Every Woman Counts

Developed by the Cancer Detection Section California Department of Public Health January, 2010 Cancer Detection Programs: Every Woman Counts a Woman s Guide to Breast Cancer Treatment Developed by the Cancer Detection Section California Department of Public Health January, 2010 Cancer Detection Programs: Every Woman Counts table of contents

More information

Intravesical Therapy for Bladder Cancer

Intravesical Therapy for Bladder Cancer Intravesical Therapy for Bladder Cancer Norm D. Smith, M.D. Chief of Urologic Oncology Department of Urology Northwestern University Feinberg School of Medicine The Problem Bladder cancer Superficial disease

More information

October is Breast Cancer Awareness Month!

October is Breast Cancer Awareness Month! October is Breast Cancer Awareness Month! A STUDY OF CHARACTERISTICS AND MANAGEMENT OF BREAST CANCER IN TAIWAN Eric Kam-Chuan Lau, OMS II a, Jim Yu, OMSII a, Christabel Moy, OMSII a, Jian Ming Chen, MD

More information

cure Cancer A Patient s Guide

cure Cancer A Patient s Guide A Patient s Guide tometastatic Breast Cancer Detection & Diagnosis Treatment Options Coping with Symptoms & Side Effects Living with Metastatic Breast Cancer Patient Perspective Questions Resources cure

More information

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology (Patient Label)

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology (Patient Label) REVIEWED DATE / INITIALS SAFETY: Are you at risk for falls? Do you have a Pacemaker? Females; Is there a possibility you may be pregnant? ALLERGIES: Do you have any allergies to medications? If, please

More information

Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study

Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study JBUON 2013; 18(2): 314-320 ISSN: 1107-0625 www.jbuon.com E-mail: info@jbuon.com ORIGINAL ARTICLE Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective

More information

Metastatic breast cancer with secondary tumours: advice for patients and relatives

Metastatic breast cancer with secondary tumours: advice for patients and relatives Metastatic breast cancer with secondary tumours: advice for patients and relatives Metastatic breast cancer means that cancer cells from the original cancer in the breast spreads to other parts of the

More information

ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival

ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival It is logical that the Cancer Program Committee choose to review the Lung Site, as Lung is the second

More information

Lung Cancer Treatment Guidelines

Lung Cancer Treatment Guidelines Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,

More information

PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES.

PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES. PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES. Radiation Oncology Sidney Kimmel Cancer Center at Johns Hopkins Last

More information

Gail Kwarciany MSN RN-BC OCN AOCNS. February 2013

Gail Kwarciany MSN RN-BC OCN AOCNS. February 2013 Gail Kwarciany MSN RN-BC OCN AOCNS February 2013 1. List 3 risk factors for breast cancer development 2. State 3 common signs & symptoms of breast cancer 3. Describe the ACS and NCI breast cancer screening

More information

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment I ve had breast cancer treatment, and now I m having pain. Does this mean the cancer

More information

Table of Contents. Cancer Committee Chairman s Report Accountability and Quality Improvement Measures Cancer Registry Cancer Sites

Table of Contents. Cancer Committee Chairman s Report Accountability and Quality Improvement Measures Cancer Registry Cancer Sites Table of Contents 2 3 6 8 9 Cancer Committee Chairman s Report Accountability and Quality Improvement Measures Cancer Registry Cancer Sites 1 2014 Cancer Committee Thomas Sunnenberg, MD, Medical Oncology,

More information

The Impact of Taxotere on Adjuvant Breast Cancer

The Impact of Taxotere on Adjuvant Breast Cancer The Impact of Taxotere on Adjuvant Breast Cancer a report by Pierre Fumoleau and Henri Roché Centre Georges François Leclerc, Dijon, and Institut Claudius Regaud, Toulouse, France DOI: 10.17925/EOH.2005.0.0.1l

More information

Cecilia de Villiers Lead Oncology Physiotherapist Cancer Centre London/Parkside Hospital

Cecilia de Villiers Lead Oncology Physiotherapist Cancer Centre London/Parkside Hospital Cecilia de Villiers Lead Oncology Physiotherapist Cancer Centre London/Parkside Hospital Why Physiotherapy?? Consider the effects of the cancer itself. Consider the possible physical and emotional effects

More information

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center Hereditary Multifocal Breast Cancer Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center CASE STUDY 30 year old Ashkenazi Jewish woman Nulliparous Felt

More information

CHEMOTHERAPY FOR ADVANCED UROTHELIAL CANCER OF THE BLADDER. Walter Stadler, MD University of Chicago

CHEMOTHERAPY FOR ADVANCED UROTHELIAL CANCER OF THE BLADDER. Walter Stadler, MD University of Chicago CHEMOTHERAPY FOR ADVANCED UROTHELIAL CANCER OF THE BLADDER Walter Stadler, MD University of Chicago Chemotherapy Doctor Terms Drugs used to treat cancer Will attack cancer no matter where it is located

More information

National Cancer Institute. What You Need TM. To Know About. Breast Cancer. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health

National Cancer Institute. What You Need TM. To Know About. Breast Cancer. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute What You Need TM To Know About Breast Cancer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Services This is only one of

More information

Dealing with Cognitive Impairment in the Patient with Breast Cancer

Dealing with Cognitive Impairment in the Patient with Breast Cancer Dealing with Cognitive Impairment in the Patient with Breast Cancer Tim A. Ahles, Ph.D. Department of Psychiatry and Behavioral Sciences Neurocognitive Research Lab Sources of Funding Office of Cancer

More information